{
  "company": {
    "name": "CG Oncology",
    "website": "https://cgoncology.com/",
    "record": "https://startuphistory.org/c/cgoncology.com"
  },
  "status": null,
  "history_since": "2020-08-11T06:39:06.000Z",
  "baseline": {
    "snapshot_id": "f66c7bebd7a908522ee21d015d0459a06a8fd1f5724de26ce3ae323657435f18",
    "observed_at": "2020-08-11T06:39:06.000Z",
    "headline": "Developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.",
    "description": "Cold Genesys is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.",
    "evidence": "https://web.archive.org/web/20200811063906/https://www.cgoncology.com/",
    "evidence_kind": "internet_archive",
    "facts": null,
    "basis": "first_observation",
    "is_change": false
  },
  "live_captures": 2,
  "last_checked": "2026-11-06T14:33:14.313Z",
  "live_status": null,
  "messaging": [
    {
      "quote_observed_at": "2022-10-12T03:47:28.000Z",
      "variants": [
        {
          "headline": "Developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.",
          "subhead": "Cold Genesys is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.",
          "observed_at": "2020-08-11T06:39:06.000Z",
          "evidence": "https://web.archive.org/web/20200811063906/https://www.cgoncology.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.",
          "subhead": "CG Oncology is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.",
          "observed_at": "2021-01-25T23:01:51.000Z",
          "evidence": "https://web.archive.org/web/20210125230151/https://www.cgoncology.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.",
          "subhead": "CG Oncology is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.",
          "observed_at": "2022-01-19T07:35:30.000Z",
          "evidence": "https://web.archive.org/web/20220119073530/https://www.cgoncology.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "Developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.",
          "subhead": "CG Oncology is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.",
          "observed_at": "2022-10-12T03:47:28.000Z",
          "evidence": "https://web.archive.org/web/20221012034728/https://www.cgoncology.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "Developing the next evolution of oncolytic immunotherapy for patients with advanced cancers.",
      "subhead": "CG Oncology is a clinical-stage biopharmaceutical company focused on the research, acquisition and development of novel immunotherapies.",
      "from": "2020-08-11T06:39:06.000Z",
      "to": "2022-10-12T03:47:28.000Z",
      "captures": 4,
      "evidence": "https://web.archive.org/web/20221012034728/https://www.cgoncology.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2020-08-11T06:39:06.000Z",
          "to": "2022-10-12T03:47:28.000Z"
        }
      },
      "current": false
    },
    {
      "quote_observed_at": "2025-01-11T22:40:01.000Z",
      "variants": [
        {
          "headline": "Bladder cancer | Oncolytic immunotherapy | CG0070 | CG Oncology - CG Oncology |",
          "subhead": "CG Oncology is an oncolytic immunotherapy company that is intensely focused on developing bladder saving therapeutics for patients with bladder cancer.",
          "observed_at": "2024-01-04T02:52:27.000Z",
          "evidence": "https://web.archive.org/web/20240104025227/https://cgoncology.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We are focused on developing bladder-sparing oncolytic immunotherapies for patients afflicted with bladder cancer.",
          "subhead": "CG Oncology is an oncolytic immunotherapy company that is intensely focused on developing bladder saving therapeutics for patients with bladder cancer.",
          "observed_at": "2024-07-15T20:29:33.000Z",
          "evidence": "https://web.archive.org/web/20240715202933/https://cgoncology.com/",
          "evidence_kind": "internet_archive"
        },
        {
          "headline": "We are focused on developing bladder-sparing oncolytic immunotherapies for patients afflicted with bladder cancer.",
          "subhead": "CG Oncology is an oncolytic immunotherapy company that is intensely focused on developing bladder saving therapeutics for patients with bladder cancer.",
          "observed_at": "2025-01-11T22:40:01.000Z",
          "evidence": "https://web.archive.org/web/20250111224001/https://cgoncology.com/",
          "evidence_kind": "internet_archive"
        }
      ],
      "headline": "We are focused on developing bladder-sparing oncolytic immunotherapies for patients afflicted with bladder cancer.",
      "subhead": "CG Oncology is an oncolytic immunotherapy company that is intensely focused on developing bladder saving therapeutics for patients with bladder cancer.",
      "from": "2024-01-04T02:52:27.000Z",
      "to": "2025-01-11T22:40:01.000Z",
      "captures": 3,
      "evidence": "https://web.archive.org/web/20250111224001/https://cgoncology.com/",
      "evidence_kind": "internet_archive",
      "seen": {
        "between": {
          "from": "2024-01-04T02:52:27.000Z",
          "to": "2025-01-11T22:40:01.000Z"
        }
      },
      "current": true
    }
  ],
  "changes": [
    {
      "n": 1,
      "id": "page-5a21e3d6c92a336eeb7067fe091e9e93f9381be1f6f82a2900a270422cf05c0c:d2306788fb52621ba605733bdab6244b9d354a470e60f4fec97c2a624bb0f7c2:investors:1550bf2ba5a7549f",
      "before_evidence": "https://web.archive.org/web/20221012034728/https://www.cgoncology.com/",
      "before_evidence_kind": "internet_archive",
      "kind": "investors",
      "label": "Investors",
      "summary": "Now shows investor logos: acorn bioventures, ally bridge group, decheng capital, kissei pharmaceutical, lepu medical, longitude capital, malin corporation, ori capital and 2 more.",
      "between": {
        "from": "2022-10-12T03:47:28.000Z",
        "to": "2023-01-28T06:30:00.000Z"
      },
      "evidence": "https://web.archive.org/web/20230128063000/https://www.cgoncology.com/",
      "evidence_kind": "internet_archive",
      "basis": "page_facts",
      "topic": "https://startuphistory.org/t/added-investor-logos"
    }
  ],
  "update": null,
  "method": {
    "version": "messaging-v1",
    "description": "https://startuphistory.org/method"
  },
  "license": "CC-BY-4.0",
  "cite": "StartupHistory, “CG Oncology” company record, https://startuphistory.org/c/cgoncology.com"
}